Skip to main content
Clinical Trials/ACTRN12619000829112
ACTRN12619000829112
Completed
Phase 2

Resuscitation in Paediatric Sepsis Using Metabolic Support– A Randomized Controlled Trial to Assess Impact on Survival Free of Organ Dysfunction

niversity of Queensland0 sites60 target enrollmentJune 7, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Sepsis
Sponsor
niversity of Queensland
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2019
End Date
June 7, 2021
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Queensland

Eligibility Criteria

Inclusion Criteria

  • Children age \=\>28 days and \<18 years which are admitted to the Paediatric Intensive Care Unit with a diagnosis of suspected septic shock requiring vasopressors/inotropes for \>2hours (i.e. fluid\-refractory shock).

Exclusion Criteria

  • \- Preterm babies born \<34 weeks gestation that have a corrected age of \<28 days
  • \- Known chronic renal failure not related to sepsis
  • \- Known chronic hepatic failure not related to sepsis
  • \- Known diseases affecting the steroid axis, including pituitary disease, congenital adrenal hypoplasia, Cushing or Addison’s disease
  • \- Palliative care patient/patient with limitation of treatment (not for inotropes, CPR, ECLS, intubation and ventilation)
  • \- Cardiopulmonary arrest in the past two hours requiring CPR \>2 min, or death is deemed to be imminent or inevitable
  • \- Major bleeding with haemorrhagic shock
  • \- Sepsis is not likely to be the cause of shock
  • \- Known glucose\-6 phosphate dehydrogenase (G\-6PD) deficiency
  • \- Patients with sepsis/septic shock transferred form another ICU or hospital who have been treated with inotropes for septic shock for \>24 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials